Doi.org/10.1179/1973947815Y.0000000053
Jump to navigation
Jump to search
Target Article[edit | edit source]
Risk of gastrointestinal perforation in cancer patients receiving ramucirumab: a meta-analysis of randomized controlled trials; Wang Z, Shang J, Zhang L, Liu P, Xie Y, Zhou Q. ; Journal of Chemotherapy; 2016; https://doi.org/10.1179/1973947815Y.0000000053
Article providing comments[edit | edit source]
Comment on: Risk of gastrointestinal perforation in cancer patients receiving ramucirumab: a meta-analysis of randomized controlled trials; Sashegyi, Andreas; Zhang, Yawei; Lin, Yong; Binder, Polina; Ferry, David; ; Journal of Chemotherapy; 2017-1-2 https://doi.org/10.1080/1120009x.2015.1113023
Summary[edit | edit source]
Note: Opened to append information.